Trial Profile
Addition of aliskiren to the other antihypertensive drug in patients with primary hypertension
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Pharmacodynamics
- 08 Dec 2015 New trial record